What is Nuubo?
Nuubo specializes in developing disruptive, non-invasive, and wireless monitoring technology utilizing textiles for medium and long-term cardiac monitoring. Their advanced aECG system offers healthcare professionals a novel perspective on remote patient care, characterized by high predictability and flexibility. Designed for patient comfort and ease of use, Nuubo's textile electrode technology ensures high compliance levels while maintaining optimal ECG signal quality, facilitating seamless integration into daily patient activities.
How much funding has Nuubo raised?
Nuubo has raised a total of $4M across 1 funding round:
Unspecified
$4M
Unspecified (2014): $4M with participation from CRB Inverbu00edo and Fides Capital
Key Investors in Nuubo
CRB Inverbu00edo
CRB Inverbio is a venture capital firm specializing in life sciences, focusing on early-stage biotech, med tech, and digital health startups. They provide strategic advisory and financing to emerging technology companies.
Fides Capital
FIDES Capital Partners is a real estate advisory and investment firm that focuses on creating and capitalizing on opportunities by aligning capital partners with asset owners, particularly in housing acquisition and development.
What's next for Nuubo?
With the recent major strategic investment, Nuubo is poised to further enhance its market presence and technological development in the remote cardiac monitoring space. This capital infusion is expected to accelerate the company's growth trajectory, enabling broader adoption of its textile-based monitoring solutions. The focus will likely be on expanding its reach within the healthcare professional network and solidifying its position as a leader in patient-centric cardiac diagnostics.
See full Nuubo company page
